Lupalbigenin, a natural product isolated and purified from the roots of Glycyrrhiza uralensis Fisch, sensitizes detachment-induced cell death in human lung cancer cell through down-regulation of pro-survival proteins, and shows promising cytotoxic effects toward HL-60 cells.

Lupalbigenin, a natural product isolated and purified from the roots of Glycyrrhiza uralensis Fisch, sensitizes detachment-induced cell death in human lung cancer cell through down-regulation of pro-survival proteins, and shows promising cytotoxic effects toward HL-60 cells.

Lupanine, a natural product isolated and purified from the herbs of Cytisus scoparius, has antimicrobial activity and a weak sedative effect on the central nervous system, interaction with specific drugs used for treatment of the CNS and for analgesic activity.

Lupanine, a natural product isolated and purified from the herbs of Cytisus scoparius, has antimicrobial activity and a weak sedative effect on the central nervous system, interaction with specific drugs used for treatment of the CNS and for analgesic activity.

Luteollin 5-glucoside is a natural product isolated and purified from the herb of Dracocephalum ruyschiana L. with antioxidant activity, which can inhibit lipid peroxidation, and has DPPH radical-scavenging activity.

Luteollin 5-glucoside is a natural product isolated and purified from the herb of Dracocephalum ruyschiana L. with antioxidant activity, which can inhibit lipid peroxidation, and has DPPH radical-scavenging activity.

Luteone is a natural product isolated and purified from the herbs of Erythrina variegata Linn., possessing antifungal activity sufficient to support its proposed role as pre-infectional resistance factors.

Luteone is a natural product isolated and purified from the herbs of Erythrina variegata Linn., possessing antifungal activity sufficient to support its proposed role as pre-infectional resistance factors.

High affinity inhibitor of phenylethanolamine-N-methyltransferase (PNMT) (Ki = 0.09 μM in vitro). Suppresses the release of growth hormone in an in vivo rat model.

LY255283 is selective, competitive antagonist of BLT2 receptors (IC50 values are ~ 1 and > 10 μM at human recombinant BLT2 and BLT1 receptors respectively), and inhibits LTB4-induced contraction of lung parenchyma (pA2 = 7.2), and reduces LTB4-mediated airway obstruction in guinea pigs following i.v. and oral administration.

LY255283 is selective, competitive antagonist of BLT2 receptors (IC50 values are ~ 1 and > 10 μM at human recombinant BLT2 and BLT1 receptors respectively), and inhibits LTB4-induced contraction of lung parenchyma (pA2 = 7.2), and reduces LTB4-mediated airway obstruction in guinea pigs following i.v. and oral administration.

LY255283 is selective, competitive antagonist of BLT2 receptors (IC50 values are ~ 1 and > 10 μM at human recombinant BLT2 and BLT1 receptors respectively), and inhibits LTB4-induced contraction of lung parenchyma (pA2 = 7.2), and reduces LTB4-mediated airway obstruction in guinea pigs following i.v. and oral administration.

LY255283 is selective, competitive antagonist of BLT2 receptors (IC50 values are ~ 1 and > 10 μM at human recombinant BLT2 and BLT1 receptors respectively), and inhibits LTB4-induced contraction of lung parenchyma (pA2 = 7.2), and reduces LTB4-mediated airway obstruction in guinea pigs following i.v. and oral administration.

LY255283 is selective, competitive antagonist of BLT2 receptors (IC50 values are ~ 1 and > 10 μM at human recombinant BLT2 and BLT1 receptors respectively), and inhibits LTB4-induced contraction of lung parenchyma (pA2 = 7.2), and reduces LTB4-mediated airway obstruction in guinea pigs following i.v. and oral administration.

LY2606368 (Prexasertib) is a selective Chk1 inhibitor with IC50 value

LY2606368 (Prexasertib) is a selective Chk1 inhibitor with IC50 value

LY2606368 (Prexasertib) is a selective Chk1 inhibitor with IC50 value

LY2606368 (Prexasertib) is a selective Chk1 inhibitor with IC50 value

LY2606368 (Prexasertib) is a selective Chk1 inhibitor with IC50 value